Scarica l'app Stockscreener
239.78
1.12%
2.65
Pre-mercato:
242.99
3.21
+1.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$237.13
Aprire:
$237.99
Volume 24 ore:
702.85K
Relative Volume:
0.84
Capitalizzazione di mercato:
$35.23B
Reddito:
$4.81B
Utile/perdita netta:
$1.11B
Rapporto P/E:
31.76
EPS:
7.55
Flusso di cassa netto:
$1.35B
1 W Prestazione:
+2.55%
1M Prestazione:
-1.17%
6M Prestazione:
+16.43%
1 anno Prestazione:
+40.46%
Intervallo 1D:
$235.88
$240.37
Intervallo di 1 settimana:
$227.26
$240.60
Portata 52W:
$170.39
$260.49
Resmed Inc Stock (RMD) Company Profile
Nome
Resmed Inc
Settore
Industria
Telefono
(858) 746-2400
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Confronta RMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
239.78 | 35.23B | 4.81B | 1.11B | 1.35B | 7.55 |
|
ISRG
Intuitive Surgical Inc
|
592.64 | 211.09B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
237.38 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.37 | 41.73B | 9.76B | 1.16B | 665.00M | 2.34 |
|
WST
West Pharmaceutical Services Inc
|
336.34 | 24.40B | 2.88B | 499.60M | 321.60M | 6.74 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-16 | Iniziato | Goldman | Buy |
| 2025-01-10 | Iniziato | Piper Sandler | Neutral |
| 2024-12-13 | Iniziato | Stifel | Hold |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-09-18 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | Downgrade | Needham | Buy → Hold |
| 2024-06-25 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-06-24 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-05 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | Iniziato | UBS | Buy |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-01-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-09-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-08-15 | Downgrade | CLSA | Buy → Outperform |
| 2022-08-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-01-28 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-01-13 | Aggiornamento | CLSA | Outperform → Buy |
| 2022-01-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-10-22 | Aggiornamento | CLSA | Underperform → Outperform |
| 2021-08-02 | Downgrade | CLSA | Outperform → Sell |
| 2021-08-02 | Downgrade | Needham | Buy → Hold |
| 2021-07-28 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-14 | Iniziato | RBC Capital Mkts | Underperform |
| 2021-06-28 | Downgrade | Citigroup | Buy → Neutral |
| 2021-06-22 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-06-22 | Iniziato | Robert W. Baird | Neutral |
| 2021-06-21 | Reiterato | Needham | Buy |
| 2021-06-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-09 | Aggiornamento | CLSA | Sell → Outperform |
| 2021-05-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-30 | Downgrade | Citigroup | Buy → Neutral |
| 2021-03-16 | Aggiornamento | Needham | Hold → Buy |
| 2020-11-02 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-10-27 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-01 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Iniziato | CLSA | Underperform |
| 2020-01-31 | Downgrade | UBS | Buy → Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Perform |
| 2019-11-22 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | Aggiornamento | UBS | Neutral → Buy |
| 2019-07-16 | Downgrade | UBS | Buy → Neutral |
| 2019-05-06 | Aggiornamento | UBS | Neutral → Buy |
| 2019-04-18 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-01-25 | Downgrade | Goldman | Buy → Neutral |
| 2019-01-25 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | Iniziato | Goldman | Buy |
Mostra tutto
Resmed Inc Borsa (RMD) Ultime notizie
ChartWatch ASX Scans: Pointerra, Cyclone Metals, Ingenia Communities, Macquarie Group, Resmed, Audinate, Dicker Data, Weebit Nano - MSN
Assistive Technology Market Set to Witness Significant Growth by 2025-2032: Sunrise Medical LLC., Tobii AB, - EIN News
Assenagon Asset Management S.A. Sells 14,445 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Sold by Assenagon Asset Management S.A. - Defense World
ResMed Gains 37.8% in a Year: What's Driving the Stock? - MSN
Integrated Investment Consultants LLC Makes New Investment in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed (NYSE:RMD) Research Coverage Started at The Goldman Sachs Group - Defense World
1,453 Shares in ResMed Inc. (NYSE:RMD) Bought by Occidental Asset Management LLC - MarketBeat
Goldman Sachs tips ResMed shares to rocket 30% to a record high - MSN
ResMed Inc. stock rises Friday, outperforms market - MarketWatch
Goldman Sachs starts coverage on ResMed with "buy" rating - MSN
The Goldman Sachs Group Begins Coverage on ResMed (NYSE:RMD) - MarketBeat
ASX Broker Moves: Upgrades for Baby Bunting, Resmed vs Downgrades for Computershare, Monadelphous, Beach Energy - MSN
ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch
Peak Financial Advisors LLC Invests $2.97 Million in ResMed Inc. (NYSE:RMD) - MarketBeat
Board of the Pension Protection Fund Makes New $915,000 Investment in ResMed Inc. (NYSE:RMD) - MarketBeat
The Zacks Analyst Blog Highlights Vertiv, Goldman Sachs, ResMed, Ralph Lauren and Amazon - Yahoo Finance
Czech National Bank Raises Stock Position in ResMed Inc. (NYSE:RMD) - Defense World
ResMed shares are up 42% in a year. This shows why they could still be great value - MSN
ResMed shares are in a two-month lull. Is this a chance to buy? - MSN
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Respiratory Devices Market Set to Witness Significant Growth by 2024-2031 | Medtronic, Hamilton Medical, - EIN News
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
Zacks.com featured highlights Chipotle Mexican Grill, ResMed and ServiceNow - Yahoo Finance
ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan - TipRanks
Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus.com
Piper Sandler Initiates Coverage on ResMed (NYSE:RMD) - Defense World
Is There An Opportunity With ResMed Inc.'s (NYSE:RMD) 31% Undervaluation? - Yahoo Finance
Piper Sandler Initiates Coverage of ResMed (RMD) with Neutral Recommendation - MSN
ResMed CFO Brett Sandercock sells shares worth $234,040 By Investing.com - Investing.com Australia
ResMed CFO Brett Sandercock sells shares worth $234,040 - Investing.com India
ResMed Inc. stock outperforms market despite losses on the day - MarketWatch
Piper Sandler Begins Coverage on ResMed (NYSE:RMD) - MarketBeat
Piper Sandler starts ResMed stock at Neutral, says execution rock solid By Investing.com - Investing.com South Africa
Piper Sandler starts ResMed stock at Neutral, says execution rock solid - Investing.com India
What 5 Analyst Ratings Have To Say About ResMed - Benzinga
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025 - GlobeNewswire
Sleep Study Equipment Market Seeking Excellent Growth | ResMed, - openPR
ResMed Inc. (NYSE:RMD) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
ResMed Inc. (NYSE:RMD) Given Average Recommendation of “Hold” by Brokerages - Defense World
Resmed Inc Officer Plans Further Sale of Common Shares - TipRanks
ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why - MSN
Here's Why ResMed (RMD) is a Strong Growth Stock - MSN
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
Birch Capital Management LLC Raises Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Nordea Investment Management AB Acquires 215,561 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. stock rises Monday, outperforms market - MarketWatch
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
ResMed Chairman Emeritus Disposes Shares in Planned Transaction - MSN
ResMed Inc. Reports Change in Beneficial Ownership - MSN
ResMed's Quarterly Earnings Preview: What You Need to Know - Nasdaq
Resmed Inc Azioni (RMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):